Eloxx Pharmaceuticals
Massachusetts, United States · Biotechnology, Health Care, Therapeutics
Eloxx Pharmaceuticals, Inc. is a leader in ribosomal RNA-targeted genetic therapies for rare diseases with nonsense mutations.
Key facts
- Headquarters
- Massachusetts, United States
- Employees
- 13
- Industries
- Biotechnology, Health Care, Therapeutics
- Status
- Public (ELOX)
- Website
- www.eloxxpharma.com
- Company page
Recent activity at Eloxx Pharmaceuticals
- : Eloxx Pharmaceuticals Appoints T.R. Srinivas as Chief Medical Officer
- : SEC 8-K (5.02): On October 19, 2026, Eloxx Pharmaceuticals, Inc. increased the size of its Board of Directors from five to six members and appointed Geno J. Germano to fill the newly created vacancy. Mr. Germano, a veteran in the pharmaceutical and life sciences industry with over 35 years of experience, will serve until the 2027 annual meeting of stockholders. His past leadership roles include President and CEO of Elucida Oncology, and President of Intrexon Corporation. The appointment is significant as Mr. Germano has a robust background with prominent companies, which may enhance Eloxx's strategic initiatives and governance standards. Notably, he is deemed independent according to Nasdaq standards, which could bolster investor confidence.
- : SEC 8-K (5.02): On May 27, 2026, Eloxx Pharmaceuticals, Inc. appointed Stephen W. Webster and Nina Kjellson to its Board of Directors, reducing the size of the Board from six to five members. Mr. Webster will serve on the Audit Committee and the Nominating & Corporate Governance Committee, while Ms. Kjellson will serve on the Compensation Committee and the Nominating & Corporate Governance Committee. Mr. Webster is regarded as 'independent' under Nasdaq listing standards and qualifies as a 'financial expert.' His extensive background includes serving as CFO for Spark Therapeutics and Optimer Pharmaceuticals, both significant players in the biotechnology sector. This change in leadership is strategic as it aims to strengthen the Company's governance and financial oversight.
- : Eloxx Pharmaceuticals Announces Pipeline and Financing Updates
Leadership
- Roger, Vice President of Chemistry
- T.R. Srinivas, M.D., Chief Medical Officer
Verified email and direct lines for Eloxx Pharmaceuticals’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.
Employee benefit plans
Eloxx Pharmaceuticals files 2 employee benefit plans with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.
Eloxx Pharmaceuticals in the news
- Eloxx Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update - PR Newswire (Aug 12, 2026)
- Eloxx Pharmaceuticals Announces First Patients Dosed in Phase 2b EXACT Study of Exaluren in Nonsense Mutation Alport Syndrome - Morningstar (Sep 11, 2026)
- Eloxx Pharmaceuticals Announces Key Corporate Accomplishments - GlobeNewswire (Nov 12, 2024)
- Eloxx Pharmaceuticals Announces Reverse Stock Split Effective - citybiz (Dec 01, 2022)
- A former Pfizer executive joins Eloxx's board - Stock Titan (Oct 19, 2026)
- Eloxx Pharmaceuticals, Inc. (ELOX) stock price, news, quote and history - Yahoo Finance Australia (Jun 03, 2018)
- Eloxx Pharmaceuticals, Inc. Announces Pricing of $66.0 Million Public Offering and Uplisting to Nasdaq - PR Newswire (Jun 08, 2026)
Companies similar to Eloxx Pharmaceuticals
- SRTD biotech · Biotechnology, Health Care, Therapeutics
- LTR Pharma Limited · Biotechnology, Health Care, Therapeutics
- MitoRx Therapeutics · Biotechnology, Health Care, Therapeutics
- Junevity · Biotechnology, Health Care, Therapeutics
- TNF Pharmaceuticals · Biotechnology, Health Care, Therapeutics
About Eloxx Pharmaceuticals: questions and answers
What does Eloxx Pharmaceuticals do?
Eloxx Pharmaceuticals, Inc. is a leader in ribosomal RNA-targeted genetic therapies for rare diseases with nonsense mutations.
Where is Eloxx Pharmaceuticals headquartered?
Eloxx Pharmaceuticals is headquartered in Massachusetts, United States.
How many employees does Eloxx Pharmaceuticals have?
Eloxx Pharmaceuticals has about 13 employees.
Who leads Eloxx Pharmaceuticals?
Roger is a Vice President of Chemistry at Eloxx Pharmaceuticals.
What is the latest news on Eloxx Pharmaceuticals?
On Oct 20, 2026, Eloxx Pharmaceuticals Appoints T.R. Srinivas as Chief Medical Officer
Is Eloxx Pharmaceuticals a public company?
Yes. Eloxx Pharmaceuticals is publicly traded under the ticker ELOX.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy